Articles by Disease (Neuroblastoma)

Identification and Targeting of Tumor Escape Mechanisms: A New Hope for Cancer Therapy?

Journal: Current Pharmaceutical Design
Volume: 9
Page: 2009-2023
Author(s): Elke S. Bergmann-Leitner, Elizabeth H. Duncan and Wolfgang W. Leitner

Src Family Kinases: Potential Targets for the Treatment of Human Cancer and Leukemia

Journal: Current Pharmaceutical Design
Volume: 9
Page: 2043-2059
Author(s): Markus Warmuth, Robert Damoiseaux, Yi Liu, Doriano Fabbro and Nathanael Gray

Renaissance of the Biologically Active Vitamin A Derivatives: Established and Novel Directed Therapies for Cancer and Chemoprevention

Journal: Current Pharmaceutical Design
Volume: 9
Page: 2067-2077
Author(s): J. Brtko and J. Thalhamer

Brain Nitric Oxide and Its Dual Role in Neurodegeneration / Neuroprotection: Understanding Molecular Mechanisms to Devise Drug Approaches

Journal: Current Medicinal Chemistry
Volume: 10
Page: 2147-2174
Author(s): Antonio Contestabile, Barbara Monti, Andrea Contestabile and Elisabetta Ciani

Enzyme / Abzyme Prodrug Activation Systems: Potential Use in Clinical Oncology

Journal: Current Pharmaceutical Design
Volume: 9
Page: 2113-2130
Author(s): Yoshisuke Nishi

The Adenine Nucleotide Translocator: A New Potential Chemotherapeutic Target

Journal: Current Drug Targets
Volume: 4
Page: 517-524
Author(s): Anne-Sophie Belzacq and Catherine Brenner

Thirty Years of Polyamine-Related Approaches to Cancer Therapy. Retrospect and Prospect. Part 1. Selective Enzyme Inhibitors

Journal: Current Drug Targets
Volume: 4
Page: 537-564
Author(s): Nikolaus Seiler